Andreas Halvorsen’s Charles River Laboratories CRL Stock Holding History

Andreas Halvorsen’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-394,089	Closed	-$79.5M	–	88
2023 Q1	$79.5M	Sell	394,089 -121,079	-24%	-$27.4M	0.37%	50
2022 Q4	$112M	Sell	515,168 -143,310	-22%	-$31.3M	0.56%	46
2022 Q3	$130M	Buy	658,478 +105,069	+19%	+$22.7M	0.6%	49
2022 Q2	$118M	Buy	553,409 +31,756	+6%	+$7.76M	0.54%	49
2022 Q1	$148M	Buy	521,653 +131,524	+34%	+$40.6M	0.6%	46
2021 Q4	$147M	Buy	390,129 +212,726	+120%	+$82.6M	0.42%	59
2021 Q3	$73.2M	Sell	177,403 -174,465	-50%	-$72.5M	0.2%	75
2021 Q2	$130M	Sell	351,868 -96,848	-22%	-$32.3M	0.39%	57
2021 Q1	$130M	Buy	+448,716	New	+$125M	0.39%	60

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Andreas Halvorsen's CRL Position: Q2 2023 in Review

Andreas Halvorsen sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 394,089 shares — an estimated $79.5M sold.

Andreas Halvorsen first reported a position in CRL in Q1 2021 and held it in 9 quarters. The position peaked at $148M in Q1 2022. 613 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

Andreas Halvorsen reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
Andreas Halvorsen sold 394,089 Charles River Laboratories shares in Q2 2023, an estimated $79.5M.
Andreas Halvorsen first reported a position in Charles River Laboratories in Q1 2021 and held it in 9 quarters.
Andreas Halvorsen's Charles River Laboratories position peaked at $148M in Q1 2022.
613 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Viking Global Investors's 13F filing for Q2 2023, filed 14 Aug 2023.